Table 2 Data showing particle size distribution, zeta potential and entrapment efficiency in different nanoparticle formulation
From: Extended levobunolol release from Eudragit nanoparticle-laden contact lenses for glaucoma therapy
Formulation code | Particle size (nm) ± SD | Zeta potential (mV) ± SD | PDI ± SD | Entrapment efficiency (%) ± SD |
|---|---|---|---|---|
F1 | 235.87 ± 6.87 | − 29.9 ± 2.13 | 0.341 ± 0.039 | 67.701 ± 1.902 |
F2 | 135.04 ± 6.93 | − 22.3 ± 4.72 | 0.485 ± 0.074 | 80.564 ± 2.938 |
F3 | 102.61 ± 3.92 | − 22.2 ± 2.76 | 0.415 ± 0.027 | 86.995 ± 1.902 |
F4 | 304.62 ± 15.56 | − 18.3 ± 5.95 | 0.372 ± 0.055 | 63.152 ± 1.245 |
F5 | 233.55 ± 5.920 | − 23.8 ± 5.39 | 0.338 ± 0.060 | 70.524 ± 2.414 |
F6 | 150.04 ± 7.74 | − 29.7 ± 2.02 | 0.368 ± 0.030 | 77.113 ± 2.591 |
F7 | 168.61 ± 13.56 | − 26.18 ± 3.55 | 0.387 ± 0.032 | 68.172 ± 2.121 |